格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-071453 Act: 34 Size: 41 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-069501 Act: 34 Size: 35 KB 网页链接
$Alterity医疗(ATHE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-113054 Act: 34 Size: 57 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-066878 Act: 34 Size: 633 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-066273 Act: 34 Size: 35 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-063646 Act: 34 Size: 872 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-063647 Act: 34 Size: 35 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-058609 Act: 34 Size: 40 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-058153 Act: 34 Size: 26 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-058146 Act: 34 Size: 80 KB 网页链接